FI750014A - - Google Patents

Info

Publication number
FI750014A
FI750014A FI750014A FI750014A FI750014A FI 750014 A FI750014 A FI 750014A FI 750014 A FI750014 A FI 750014A FI 750014 A FI750014 A FI 750014A FI 750014 A FI750014 A FI 750014A
Authority
FI
Finland
Application number
FI750014A
Other languages
Finnish (fi)
Other versions
FI54053B (fi
FI54053C (fi
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI750014A publication Critical patent/FI750014A/fi
Publication of FI54053B publication Critical patent/FI54053B/fi
Application granted granted Critical
Publication of FI54053C publication Critical patent/FI54053C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FI750014A 1974-01-14 1975-01-06 Foerfarande foer isolering av hemagglutinin- och neuraminidasbestaondsdelarna ur ett influensavirus FI54053C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (ko) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
FI750014A true FI750014A (ko) 1975-07-15
FI54053B FI54053B (fi) 1978-06-30
FI54053C FI54053C (fi) 1978-10-10

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750014A FI54053C (fi) 1974-01-14 1975-01-06 Foerfarande foer isolering av hemagglutinin- och neuraminidasbestaondsdelarna ur ett influensavirus

Country Status (27)

Country Link
JP (2) JPS58407B2 (ko)
AT (1) AT345449B (ko)
AU (1) AU500250B2 (ko)
BE (1) BE824372A (ko)
CA (1) CA1049406A (ko)
CH (1) CH589453A5 (ko)
CS (1) CS191254B2 (ko)
DD (1) DD116239A5 (ko)
DE (1) DE2500785B2 (ko)
DK (1) DK140003B (ko)
ES (1) ES433759A1 (ko)
FI (1) FI54053C (ko)
FR (1) FR2257305B1 (ko)
GB (1) GB1498261A (ko)
HK (1) HK56380A (ko)
HU (1) HU173920B (ko)
IE (1) IE40794B1 (ko)
IL (1) IL46426A (ko)
MY (1) MY8100204A (ko)
NL (1) NL166622C (ko)
NO (1) NO143128C (ko)
PH (1) PH14458A (ko)
PL (1) PL93689B1 (ko)
SE (1) SE427238B (ko)
SU (1) SU616997A3 (ko)
YU (1) YU41289B (ko)
ZA (1) ZA75259B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
ES433759A1 (es) 1977-02-16
PH14458A (en) 1981-07-29
IE40794L (en) 1975-07-14
YU41289B (en) 1987-02-28
DD116239A5 (ko) 1975-11-12
NO143128B (no) 1980-09-15
ATA21475A (de) 1978-01-15
NO750031L (ko) 1975-08-11
CA1049406A (en) 1979-02-27
DE2500785B2 (de) 1980-01-03
CS191254B2 (en) 1979-06-29
FI54053B (fi) 1978-06-30
JPS58407B2 (ja) 1983-01-06
SE427238B (sv) 1983-03-21
NL166622B (nl) 1981-04-15
JPS56127319A (en) 1981-10-06
FR2257305B1 (ko) 1982-03-19
IL46426A0 (en) 1975-04-25
DE2500785A1 (de) 1975-07-31
FI54053C (fi) 1978-10-10
AU500250B2 (en) 1979-05-17
HK56380A (en) 1980-10-16
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
GB1498261A (en) 1978-01-18
DK140003B (da) 1979-06-05
SU616997A3 (ru) 1978-07-25
PL93689B1 (ko) 1977-06-30
DE2500785C3 (ko) 1980-09-11
NL166622C (nl) 1981-09-15
DK1475A (ko) 1975-09-01
JPS6035326B2 (ja) 1985-08-14
DK140003C (ko) 1979-10-29
YU5875A (en) 1984-04-30
JPS50100224A (ko) 1975-08-08
AT345449B (de) 1978-09-11
IE40794B1 (en) 1979-08-15
HU173920B (hu) 1979-09-28
IL46426A (en) 1978-01-31
MY8100204A (en) 1981-12-31
AU7730575A (en) 1976-07-15
CH589453A5 (ko) 1977-07-15
FR2257305A1 (ko) 1975-08-08
NL7500301A (nl) 1975-07-16
SE7500130L (ko) 1975-07-15
BE824372A (fr) 1975-07-14

Similar Documents

Publication Publication Date Title
FI750014A (ko)
AU7138274A (ko)
CH572242A5 (ko)
CH1479975A4 (ko)
BE827400A (ko)
BE829996A (ko)
BG19665A1 (ko)
BG19743A1 (ko)
BG19932A1 (ko)
BG19962A1 (ko)
BG19972A1 (ko)
BG20039A1 (ko)
BG20143A1 (ko)
BG20237A1 (ko)
BG20444A1 (ko)
BG20460A1 (ko)
BG20643A1 (ko)
BG20855A2 (ko)
BG21119A1 (ko)
BG21784A1 (ko)
BG21787A1 (ko)
BG22207A1 (ko)
BG22501A1 (ko)
BG22732A1 (ko)
BG23489A1 (ko)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V